Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET.

  • Nogales, Paula
  • Velasco, Carlos
  • González-Cintado, Leticia
  • Sharysh, Diana
  • Mota-Cobián, Adriana
  • Izquierdo-Serrano, Raúl
  • Torroja, Carlos
  • Del Rio-Aledo, David
  • Morales-Cano, Daniel
  • Mota, Rubén A
  • Benguría, Alberto
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Vázquez, Jesús
  • España, Samuel
  • Carramolino, Laura
  • Mateo, Jesús
  • Bentzon, Jacob F
Positron emission tomography (PET) imaging with the radiolabeled glucose analog fluorodeoxyglucose (FDG) is used to monitor atherosclerosis in clinical trials, but there is uncertainty regarding the plaque cell types that accumulate FDG and how uptake is regulated. The long-standing view that FDG is mainly taken up by macrophages is at odds with human and experimental data, and the impact of disease activity on FDG uptake has not been examined directly. To analyze the ability of FDG-PET to monitor disease activity, we developed a model of plaque regression in minipigs with hepatic overexpression of a gain-of-function mutant of (). Atherosclerosis was induced through 12 months of high-fat feeding in the porcine model. Disease activity was then lowered for 3 months by reducing plasma cholesterol with a low-fat diet alone or in combination with the microsomal transfer protein (MTP) inhibitor BMS-212122. Plaque regression in advanced lesions of the abdominal aorta was evident from reduced lipid content, reduced necrotic core size, and partial resolution of plaque inflammation and was accompanied by a decline in FDG-PET signal. Single-cell gene expression profiling revealed that plaque regression involved substantial down-regulation of genes encoding glycolytic enzymes in smooth muscle cells (SMCs), macrophages, and lymphocytes, which was corroborated by analysis of the plaque cellular proteome. These findings in a large-animal model suggest that FDG-PET can monitor atherosclerosis because of a close association between disease activity and glycolytic enzyme expression in all of the major plaque cell types.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Enzymatic Degradation of Poly(butylene succinate) Copolyesters Synthesized with the Use of Candida antarctica Lipase B

  • Wcislek, Aleksandra
  • McClain, Andrew
  • Piegat, Agnieszka
  • Sobolewski, Peter
  • Puskas, Judit
  • El Fray, Miroslawa
  • Sonseca Olalla, Agueda|||0000-0002-2776-4399
[EN] Biodegradable polymers are an active area of investigation, particularly ones that can be produced from sustainable, biobased monomers, such as copolymers of poly(butylene succinate) (PBS). In this study, we examine the enzymatic degradation of poly(butylene succinate-dilinoleic succinate) (PBS-DLS) copolymers obtained by green enzymatic synthesis using lipase B from Candida antarctica (CALB). The copolymers differed in their hard to soft segments ratio, from 70:30 to 50:50 wt %. Enzymatic degradation was carried out on electrospun membranes (scaffolds) and compression-moulded films using lipase from Pseudomomas cepacia. Poly(epsilon-caprolactone) (PCL) was used as a reference aliphatic polyester. The degradation process was monitored gravimetrically via water uptake and mass loss. After 24 days, approx. 40% mass loss was observed for fibrous materials prepared from the PBS-DLS 70:30 copolymer, as compared to approx. 10% mass loss for PBS-DLS 50:50. Infrared spectroscopy (FTIR) and size exclusion chromatography (SEC) analysis were used to examine changes in chemical structure. Differential scanning calorimetry (DSC) and scanning light microscopy (LSM) revealed changes in degree of crystallinity, and changes in surface morphology, consistent with a surface erosion mechanism. We conclude that the obtained copolymers are suitable for tissue engineering applications thanks to tuneable degradation and lack of acidification during breakdown., This work was financially supported by the National Science Centre, Poland, underthe HARMONIA program under agreement No.UMO-2014/14/M/ST00610. ASO acknowledge the Juan de la Cierva ·(FJCI-2015-24405) contract from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Kinetic studies of biocatalyzed copolyesters of poly(butylene succinate) (PBS) containing fully bio-based dilinoleic diol

  • Sonseca Olalla, Agueda|||0000-0002-2776-4399
  • McClain, Andrew
  • Puskas, Judit E.
  • El Fray, Miroslawa
[EN] A series of segmented bio-copolyesters based on crystallizable hard segments of poly(butylene succinate) (PBS) and fully bio-based dilinoleic diol (DLAOH), creating dilinoleic succinate (DLS) soft segments, were prepared by enzymatically catalyzed polycondensation. The kinetic studies performed with H-1 NMR and SEC have proved incorporation of highly hydrophobic DLAOH into the polymer backbone. We found that the efficacy of DLAOH incorporation was limited by the catalytic pocket size of the enzyme and its hydrophobic nature favouring the formation of long PBS sequences, especially at the early synthesis stages and having an effect on final content of soft segments compared to feed ratio. Based on quantitative C-13 NMR analysis we found that copolymers had R-values lower than 1, that is low degree of randomness. Differential scanning calorimetry (DSC) revealed changes in degree of crystallinity and the presence of a phase mixed system., This work is financially supported by National Science Centre, Poland, under the HARMONIA scheme (agreement No. UMO-2014/14/M/ST8/00610). A.S. wants to acknowledge the "Juan de la Cierva" (FJCI-2015-24405) contract from the Spanish Ministry of Science, Innovation and Universities.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Architectured helically coiled scaffolds from elastomeric poly(butylene succinate) (PBS) copolyester via wet electrospinning

  • Sonseca Olalla, Agueda|||0000-0002-2776-4399
  • Sahay, Rahul
  • Stepien, Karolina
  • Bukala, Julia
  • Wcislek, Aleksandra
  • McClain, Andrew
  • Sobolewski, Peter
  • Sui, XiaoMeng
  • Puskas, Judit E.
  • kohn, Joachim
  • Wagner, H. Daniel
  • El Fray, Miroslawa
[EN] Electrospinning is one of the most investigated methods used to produce polymeric fiber scaffolds that mimic the morphology of native extracellular matrix. These structures have been extensively studied in the context of scaffolds for tissue regeneration. However, the compactness of materials obtained by traditional electrospinning, collected as two-dimensional non-woven scaffolds, can limit cell infiltration and tissue ingrowth. In addition, for applications in smooth muscle tissue engineering, highly elastic scaffolds capable of withstanding cyclic mechanical strains without suffering significant permanent deformations are preferred. In order to address these challenges, we report the fabrication of microscale 3D helically coiled scaffolds (referred as 3D-HCS) by wet-electrospinning method, a modification of the traditional electrospinning process in which a coagulation bath (non-solvent system for the electrospun material) is used as the collector. The present study, for the first time, successfully demonstrates the feasibility of using this method to produce various architectures of 3D helically coiled scaffolds (HCS) from segmented copolyester of poly (butylene succinate-co-dilinoleic succinate) (PBS-DLS), a thermoplastic elastomer. We examined the role of process parameters and propose a mechanism for the HCS formation. Fabricated 3D-HCS showed high specific surface area, high porosity, and good elasticity. Further, the marked increase in cell proliferation on 3D-HCS confirmed the suitability of these materials as scaffolds for soft tissue engineering., This work is financially supported by National Science Centre, Poland, under the HARMONIA scheme (agreement No. UMO-2014/14/M/ST8/00610). The authors thank Dr. Karol Fijalkowski (Faculty of Biotechnology and Animal Husbandry, ZUT) for access to the multifunctional plate reader. A. S. acknowledges the "Juan de la Cierva" (FJCI-2015-24405) contract from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO), Spain.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Advanced lipoprotein parameters could better explain atheromatosis in non-diabetic chronic kidney disease patients

  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Perpiñan, Héctor
  • Amigó, Núria|||0000-0002-0116-9145
  • Castro Boque, Eva
  • Alonso Pedrol, Núria|||0000-0001-9687-8050
  • Mauricio, Didac|||0000-0002-2868-0250
  • Fernandez, Elvira
  • Valdivielso, José Manuel|||0000-0003-1343-0184
Background: Chronic kidney disease (CKD) patients have a high burden of atheromatous cardiovascular disease (ASCVD) not fully explained by traditional lipid parameters. Lipoprotein composition and subclass particle number information could improve ASCVD risk assessment. The objective of this study is to investigate the association of advanced lipoprotein parameters with the risk of atheromatosis in a subpopulation of the NEFRONA study. Methods: This was a cross-sectional study in 395 non-diabetic individuals (209 CKD and 186 non-diabetic and non-CKD) without statin therapy. Vascular ultrasound examination assessing 10 territories was combined with advanced lipoprotein testing performed by nuclear magnetic resonance spectroscopy. Logistic regression was used to estimate adjusted odds ratios (ORs) per 1 standard deviation increment. Results: Atheromatosis was more prevalent in CKD patients (33.9% versus 64.6%). After adjusting for age, gender, smoking habit and CKD stage, the amount of triglycerides (TGs) within low-density lipoprotein (LDL) lipoproteins was independently and positively associated with atheromatosis [OR 1.33; 95% confidence interval (CI) 1.03-1.74; P = 0.03]. Similarly, total and medium LDL particles (LDL-Ps) showed a positive association (OR 1.29; 95% CI 1.00-1.68; P = 0.05 and OR 1.34; 95% CI 1.04-1.75; P = 0.03, respectively). TG-loaded medium LDL-Ps were higher in CKD patients compared with controls and showed an adjusted OR of 1.40 (95% CI 1.09-1.82; P = 0.01) in non-diabetic patients (CKD and non-CKD individuals). In contrast, non-diabetic CKD patients showed a similar coefficient but the significance was lost (OR 1.2; 95% CI 0.8-1.7; P = 0.359). Conclusions: Non-diabetic CKD patients showed a higher amount of TG-loaded medium LDL-Ps compared with controls. These particles were independently associated with atheromatosis in non-diabetic patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis

  • Nuñez, Estefania|||0000-0002-0876-1264
  • Fuster, Valentín
  • Gómez-Serrano, María
  • Valdivielso, José Manuel|||0000-0003-1343-0184
  • Fernández-Alvira, Juan Miguel
  • Martínez-López, Diego
  • Rodríguez, José Manuel
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Calvo, Enrique
  • Alfayate, Alvaro
  • Bermúdez-López, Marcelino|||0000-0002-3188-4158
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Fernández-Friera, Leticia
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Mendiguren, José María
  • Sánchez-Cabo, Fátima|||0000-0003-1881-1664
  • Sanz Salvo, Javier
  • Ordovás, José María
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • García-Ruiz, José Manuel
  • Ibañez, Borja|||0000-0002-5036-254X
  • Lara-Pezzi, Enrique
  • Fernández-Ortiz, Antonio
  • Martín-Ventura, José Luis
  • Vázquez, Jesús|||0000-0003-1461-5092
Background: Imaging of subclinical atherosclerosis improves cardiovascular risk prediction on top of traditional risk factors. However, cardiovascular imaging is not universally available. This work aims to identify circulating proteins that could predict subclinical atherosclerosis. Methods: Hypothesis-free proteomics was used to analyze plasma from 444 subjects from PESA cohort study (222 with extensive atherosclerosis on imaging, and 222 matched controls) at two timepoints (three years apart) for discovery, and from 350 subjects from AWHS cohort study (175 subjects with extensive atherosclerosis on imaging and 175 matched controls) for external validation. A selected three-protein panel was further validated by immunoturbidimetry in the AWHS population and in 2999 subjects from ILERVAS cohort study. Findings: PIGR, IGHA2, APOA, HPT and HEP2 were associated with subclinical atherosclerosis independently from traditional risk factors at both timepoints in the discovery and validation cohorts. Multivariate analysis rendered a potential three-protein biomarker panel, including IGHA2, APOA and HPT. Immunoturbidimetry confirmed the independent associations of these three proteins with subclinical atherosclerosis in AWHS and ILERVAS. A machine-learning model with these three proteins was able to predict subclinical atherosclerosis in ILERVAS (AUC [95%CI]:0.73 [0.70-0.74], p < 1 × 10), and also in the subpopulation of individuals with low cardiovascular risk according to FHS 10-year score (0.71 [0.69-0.73], p < 1 × 10). Interpretation: Plasma levels of IGHA2, APOA and HPT are associated with subclinical atherosclerosis independently of traditional risk factors and offers potential to predict this disease. The panel could improve primary prevention strategies in areas where imaging is not available.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Maternal iron status in early pregnancy and DNA methylation in offspring, an epigenome-wide meta-analysis

  • Taeubert, M. Jazmin|||0000-0002-8442-3929
  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Geurtsen, Madelon L.
  • Mancano, Giulia
  • Vermeulen, Marijin J.|||0000-0001-9686-8186
  • Reiss, Irwin Karl Marcel
  • Caramaschi, Doretta|||0000-0002-9740-871X
  • Sunyer Deu, Jordi|||0000-0002-2602-4110
  • Sharp, Gemma C.|||0000-0003-2906-4035
  • Júlvez, Jordi|||0000-0003-0818-4003
  • Muckenthaler, Martina|||0000-0002-3778-510X
  • Felix, Janine Frédérique
Unbalanced iron homeostasis in pregnancy is associated with an increased risk of adverse birth and childhood health outcomes. DNA methylation has been suggested as a potential underlying mechanism linking environmental exposures such as micronutrient status during pregnancy with offspring health. We performed a meta-analysis on the association of maternal early-pregnancy serum ferritin concentrations, as a marker of body iron stores, and cord blood DNA methylation. We included 1286 mother-newborn pairs from two population-based prospective cohorts. Serum ferritin concentrations were measured in early pregnancy. DNA methylation was measured with the Infinium HumanMethylation450 BeadChip (Illumina). We examined epigenome-wide associations of maternal early-pregnancy serum ferritin and cord blood DNA methylation using robust linear regression analyses, with adjustment for confounders and performed fixed-effects meta-analyses. We additionally examined whether associations of any CpGs identified in cord blood persisted in the peripheral blood of older children and explored associations with other markers of maternal iron status. We also examined whether similar findings were present in the association of cord blood serum ferritin concentrations with cord blood DNA methylation. Maternal early-pregnancy serum ferritin concentrations were inversely associated with DNA methylation at two CpGs (cg02806645 and cg06322988) in PRR23A and one CpG (cg04468817) in PRSS22. Associations at two of these CpG sites persisted at each of the follow-up time points in childhood. Cord blood serum ferritin concentrations were not associated with cord blood DNA methylation levels at the three identified CpGs. Maternal early-pregnancy serum ferritin concentrations were associated with lower cord blood DNA methylation levels at three CpGs and these associations partly persisted in older children. Further studies are needed to uncover the role of these CpGs in the underlying mechanisms of the associations of maternal iron status and offspring health outcomes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cord blood DNA methylation reflects cord blood C-reactive protein levels but not maternal levels, a longitudinal study and meta-analysis

  • Yeung, Edwina H.
  • Guan, Weihua
  • Zeng, Xuehuo
  • Salas, Lucas A.
  • Mumford, Sunni L.
  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Van Meel, Evelien R.
  • Malmberg, Anni
  • Sunyer, Jordi
  • Duijts, Liesbeth
  • Felix, Janine F.|||0000-0002-9801-5774
  • Czamara, Darina
  • Hämäläinen, Esa
  • Binder, Elisabeth B.
  • Raïkkönen, Katri|||0000-0003-3124-3470
  • Lahti, Jari|||0000-0002-4310-5297
  • London, Stephanie J.|||0000-0003-4911-5290
  • Silver, Robert M.
  • Schisterman, Enrique F.
Background: Prenatal inflammation has been proposed as an important mediating factor in several adverse pregnancy outcomes. C-reactive protein (CRP) is an inflammatory cytokine easily measured in blood. It has clinical value due to its reliability as a biomarker for systemic inflammation and can indicate cellular injury and disease severity. Elevated levels of CRP in adulthood are associated with alterations in DNA methylation. However, no studies have prospectively investigated the relationship between maternal CRP levels and newborn DNA methylation measured by microarray in cord blood with reasonable epigenome-wide coverage. Importantly, the timing of inflammation exposure during pregnancy may also result in different effects. Thus, our objective was to evaluate this prospective association of CRP levels measured during multiple periods of pregnancy and in cord blood at delivery which was available in one cohort (i.e., Effects of Aspirin in Gestation and Reproduction trial), and also to conduct a meta-analysis with available data at one point in pregnancy from three other cohorts from the Pregnancy And Childhood Epigenetics consortium (PACE). Secondarily, the impact of maternal randomization to low dose aspirin prior to pregnancy on methylation was assessed. Results: Maternal CRP levels were not associated with newborn DNA methylation regardless of gestational age of measurement (i.e., CRP at approximately 8, 20, and 36 weeks among 358 newborns in EAGeR). There also was no association in the meta-analyses (all p.